Vice President for Science and Technology, Medtronic Inc.
Ms. Bergman has more than 22 years of experience in the medical technology industry
including over 15 years of experience in research and technology management and product
development. Since February 2009, she has served as Vice President, New Therapies and
Diagnostics for Cardiac Rhythm Disease Management of Medtronic, Inc., a manufacturer of
products and therapies used in the diagnosis, treatment and monitoring of chronic medical
conditions. She previously served as Vice President, Science and Technology of Medtronic,
Inc. from April 2002 to February 2009. Ms. Bergman has been a director of the Company
since 2008. She serves as a member of the National Advisory Committee of the National
Institute of Biomedical Imaging and Bioengineering (NIBIB) of the NIH and on a number of
academic advisory boards. Ms. Bergman is a Fellow of the American Institute for Medical and
Biological Engineering (AIMBE) and was elected as a member of the National Academy of
Engineering (NAE) in February 2010. Age 53.
Professor of Genetics at the Harvard Medical School and Director of the Center for Computational Genetics in Cambridge, Massachusetts.
Dr. Church is a Professor of Genetics at the Harvard Medical School and Director of the Center for Computational Genetics in Cambridge, Massachusetts. Dr. Church pioneered technology innovations early in the development of key fields in Chemistry and Biomedicine with over 10 U.S. patents granted and several pending. His work in the first direct Genomic Sequencing and Molecular Multiplexing technology has resulted in a new paradigm in biological research. Age 55.
Former Chairman and CEO, Sigma-Aldrich Corporation
Dr. Harvey served as Chairman of the Board of Directors of the Company from 2001 to 2009.
He was our Chief Executive Officer from 1999 through 2005 and Chief Operating Officer from
1986 to 1999. Prior to 1986 during his 35-year career with the Company, Dr. Harvey served
in various executive positions at Aldrich Chemical Company, including President and Vice
President Europe, and in various sales and marketing positions at Shell International
Chemical Company. He has been a director of the Company since 1981. He is also a director
of CF Industries where he acted as lead independent director from 2005 to 2009. Age 70.
Former Executive Vice President and Chief Financial Officer S.C. Johnson & Son, Inc.
Mr. McCollum is an audit committee financial expert and has significant management
experience including more than 35 years of experience with S.C. Johnson and Son, Inc., a
global manufacturer and marketer of consumer products, where he held positions involving
accounting, treasury, taxes, internal audit, mergers and acquisitions, strategic planning,
personnel matters, international operations and general management. At S.C. Johnson and
Son., Inc., he served as Senior Vice President and Chief Financial Officer from 1997 to 2004
and as Executive Vice President and Chief Financial Officer from 2005 to 2009. From 2005 to
2009, his responsibilities also included global manufacturing. Mr. McCollum has been a
director of the Company since 2001. He is also a director of Johnson Outdoors, Inc., and
serves as Vice Chairman and director of Johnson Financial Group, a large private regional
bank holding company. Age 60.
- 6
Managing Director of Avi Nash LLC (Former partner of Goldman Sachs)
Avi M. Nash Managing Director of Avi Nash LLC, a management consulting firm in Greenwich, Connecticut, that works with global chemical industry leaders in mergers and acquisitions, capital market transactions and other strategic matters. Prior to launching his firm in 2003, he was a partner at Goldman Sachs, New York, New York, for more than five years. He has been a director of the Company since November 2005. Age 55.
Executive Vice President for Science and Technology and President, Lilly Research Laboratories of Eli Lilly and Company
Steven M. Paul Executive Vice President for Science and Technology and President of the Lilly Research Laboratories of Eli Lilly and Company, a pharmaceutical company that engages in the discovery, development, manufacture and sale of pharmaceutical products, Indianapolis, Indiana, since July 2003. He was Group Vice President of Therapeutic Area Discovery Research and Clinical Investigation for Lilly Research Laboratories, a division of Eli Lilly and Company, for more than five years until July 2003. He has been a director of the Company since November 2006. He is also a director of the Lilly Foundation, the Foundation of the NIH, Butler University and the Indianapolis Zoological Society. Age 57.
President of Reinhard & Associates (Former CFO, Dow Chemical Company)
Mr. Reinhard has more than 35 years of experience in the chemicals industry and more than
30 years of international management experience, including more than 10 years as a chief
financial officer. He is an audit committee financial expert and has significant capital markets
and finance experience. Mr. Reinhard served as Executive Vice President and Chief
Financial Officer of The Dow Chemical Company ("Dow"), a manufacturer of chemicals,
plastic materials, agricultural and other specialized products, Midland, Michigan, from 1995 to
2005. Previously, Mr. Reinhard held a variety of senior international, financial and operating
leadership positions at Dow after beginning his career there in 1970 in Brazil and other senior
operations assignments in Europe. In 1988, Mr. Reinhard was appointed Treasurer of Dow.
Mr. Reinhard served as a director of Dow from 1995 to 2007. He presently serves as
President of Reinhard & Associates, a financial advisory practice since 2006. He has been a
director of the Company since 2001. He is also a director of Colgate Palmolive Co. and Royal
Bank of Canada. Age. 64.
Rakesh was elected in November 2010. Rakesh is the President and CEO of Sigma-Aldrich. Prior to that he served as Senior Vice President and Chief Financial and Administrative Officer of Sigma-Aldrich Corporation. Mr. Sachdev joined the company in November 2008.
Prior to joining the company, he served as Senior Vice President and President, Asia Pacific at ArvinMeritor, Inc. where he also held numerous other leadership positions in finance, strategy and general management since 1999. Previously, he was with Cummins, Inc.
where he started in 1981 and was Chief Financial Officer, Automotive Business Unit, and held various other positions over many years. He was elected a Director of the Company in November, 2010.
D. Dean Spatz CEO of Watasso Ventures, a company that specializes in investing in and actively participating in the management and development of entrepreneurial start-up companies. Former Chairman and Chief Executive Officer of Osmonics, Inc., a manufacturer of water purification, fluid separation and fluid handling products and equipment, Minnetonka, Minnesota. He was founder, Chairman and Chief Executive Officer of Osmonics, Inc. for more than five years until February 2003 when Osmonics, Inc. was acquired by GE Infrastructure, a unit of General Electric Company. He has been a director of the Company since 1994. He also serves as a director of three privately held companies. Age 63.
Barrett A. Toan Former Chairman of Express Scripts, Inc., a pharmacy benefits management company, St. Louis, Missouri. He was Chairman of Express Scripts, Inc. for more than five years until May 2006. He also served as Chief Executive Officer of Express Scripts, Inc. for more than five years until March 2005. He has been a director of the Company since 2001. He is also a director of Express Scripts, Inc. and Genworth Financial, Inc. Age 60.
= Chair of the Board
= Chair
= Member
Vice President for Science and Technology, Medtronic Inc.
Former Chairman and CEO, Sigma-Aldrich Corporation 
Former Executive Vice President and Chief Financial Officer
President of Reinhard & Associates (Former CFO, Dow Chemical Company)
Former Chairman and CEO of Express Scripts, Inc.
